diverse somatic mutation patterns pathway alterations human cancers 
systematic characterization somatic mutations cancer genomes essential understanding disease developing targeted therapeutics report identification somatic mutations across similar megabases dna representing coding genes tumours comprising breast lung ovarian prostate cancer types subtypes found mutation rates sets mutated genes varied substantially across tumour types subtypes statistical analysis identified significantly mutated genes including protein kinases g-protein-coupled receptors grm8 bai3 agtrl1 also called aplnr lphn3 druggable targets integrated analysis somatic mutations copy number alterations identified another significantly altered genes including gnas indicating expanded role g alpha subunits multiple cancer types furthermore experimental analyses demonstrate functional roles mutant gnao1 g alpha subunit mutant map2k4 member jnk signalling pathway oncogenesis study provides overview mutational spectra across major human cancers identifies several potential therapeutic targets 
